Evidence map›Paper›PMID 42490872›Full record

ArticleFrontiers in immunology2026

Commentary: PCP4 inhibits the progression of prostate cancer through Ca

Wujie Chen, Fajiang Qian, Fengtong Wang, Fuquan Yang, Yuqing Shen, Mingxia Ding, Yuan Liu

Abstract readComment
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors.

Wujie Chen *Kunming Medical University, Kunming, China.
Fajiang Qian *Department of Urology, Lincang People's Hospital Linxiang District, Lingcang, Yunnan, China.
Fengtong Wang *Department of Oncology, Lincang People's Hospital Linxiang District, Lingcang, Yunnan, China.
Fuquan Yang *Medical Device Registration Production Inspection Section, China Food and Drug Administration, Medical Products Administration of Yunnan, Kunming, Yunnan, China.
Yuqing ShenDepartment of Urology, Lincang People's Hospital Linxiang District, Lingcang, Yunnan, China.
Mingxia DingKunming Medical University, Kunming, China.
Yuan LiuDepartment of Orthopedics, Chongqing Qianjiang Central Hospital, Chongqing, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

CAMKK2castration-resistant prostate cancercommentaryPCP4prostate cancer

Identifiers

PMID42490872
PMCPMC13375711

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.